Staff Reporter
,
Singapore
Press photo from gci health
The collaboration includes a phase 1 clinical study to start in the second quarter of 2025.
The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) have signed a memorandum of understanding (MoU) to advance research in acne treatment.
The collaboration includes a phase 1 clinical study involving patients with mild acne, expected to commence in the second quarter of 2025.
In addition, a translational study will be conducted to explore key biological markers that impact acne severity.
The chronic inflammatory skin condition affects a significant portion of the population, with approximately 80% of teenagers and an increasing number of adults—an estimated 40%—experiencing the condition.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
